Patents by Inventor Ilji Jeong

Ilji Jeong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted pyrazolo[1,5-a]pyrimidines as CFTR modulators
    Patent number: 11827640
    Abstract: The present disclosure provides CFTR modulator and phosphodiesterase 4 (PDE4) inhibitor compounds of the formula (Ia): and compositions including said compounds. The compounds can provide functionality for modulating CFTR, methods for treating an eye disease or disorder, and methods for treating CFTR-related indications. The present disclosure also provides methods of using said compounds and compositions for inhibiting PDE4 in a biological system or biological sample, for treating an inflammatory disease or disorder, and for treating other PDE4-related indications. Also provided are methods of preparing said compounds and compositions, and synthetic precursors of said compounds.
    Type: Grant
    Filed: October 22, 2021
    Date of Patent: November 28, 2023
    Assignee: ILDONG PHARMACEUTICAL CO., LTD.
    Inventors: Myongjae Lee, Changmok Oh, Dami Lim, Kyeong-A Kim, Seolhee Lee, Ilji Jeong, Jaeeun Ryu, Jooyun Lee, Yearin Jun, Jinsun Kwon, Te-ik Sohn, Gunhee Kim, Jungho Kim, Jongmin Yoon, Jin Hee Lee, Hongchul Yoon, Jung Woo Lee, Joontae Park, Kyung Mi An
  • CFTR MODULATOR COMPOUNDS, COMPOSITIONS, AND USES THEREOF
    Publication number: 20230080486
    Abstract: CFTR modulator compounds and compositions including said compounds are provided. The present disclosure also provides PDE4 inhibiting compounds and compositions including said compounds. Also provided are methods of using said compounds and compositions for modulating CFTR, methods for treating an eye disease or disorder and methods for treating CFTR-related indications. The present disclosure also provides methods of using said compounds and compositions for inhibiting PDE4, for treating an inflammatory disease or disorder and for treating other PDE4-related indications. Also provided are methods of preparing said compounds and compositions, and synthetic precursors of said compounds.
    Type: Application
    Filed: October 22, 2021
    Publication date: March 16, 2023
    Inventors: Myongjae Lee, Changmok Oh, Dami Lim, Kyeong-a Kim, Seolhee Lee, Ilji Jeong, Jaeeun Ryu, Jooyun Lee, Yearin Jun, Jinsun Kwon, Te-ik Sohn, Gunhee Kim, Jungho Kim, Jongmin Yoon, Jin Hee Lee, Hongchul Yoon, Jung Woo Lee, Joontae Park, Kyung Mi An